You are viewing an expired study

This study is not currently recruiting Study Participants on If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Buffalo, New York 14209

  • Peripheral Vascular Disease


A comparison of a fibrin sealant versus manual compression in stopping surgical bleeding during vascular procedures.


Inclusion Criteria: - Male and female subjects, 18 years or older, requiring elective, primary or repeat vascular procedures with at least one end-to-side femoral or upper extremity vascular access arterial anastomosis (e.g. femoral-femoral, femoral-popliteal, femoral-tibial, ilio-femoral, aorto-bifemoral, abdominal aortic aneurysm, upper extremity vascular access for dialysis) using uncoated or heparin-coated PTFE grafts and polypropylene sutures (size 5-0 or 6-0) with a 1:1 needle-to-thread ratio. - Following initial arterial clamp release, the study surgeon determines that adjunctive measures are needed to obtain haemostasis at the SAS. - Subjects must be willing to and capable of participating in the study, and provided written informed consent. Exclusion Criteria: - Subjects undergoing re-vascularisation using autologous conduits (e.g. saphenous vein) or prosthetic material other than uncoated or heparin-coated PTFE. - Subjects undergoing emergency surgery. - Subjects with any intra-operative findings that may preclude conduct of the study procedure. - Subjects with known intolerance to heparin, blood products or to one of the components of the study product. - Subjects unwilling to receive blood products. - Subjects with autoimmune immunodeficiency diseases (including known HIV). - Subjects who are known, current alcohol and / or drug abusers. - Subjects who have participated in another investigational drug or device research study within 30 days of enrolment. - Female subjects who are pregnant or nursing.

Study is Available At:

Original ID:




Secondary ID:

Study Acronym:

Brief Title:

Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures

Official Title:

A Prospective, Randomized Controlled Study to Compare the Effects of a Fibrin Sealant (FS2) Versus Manual Compression on Haemostatic Efficacy During Vascular Surgical Procedures Utilising Polytetrafluorethylene Graft Material on an End-to-Side Femoral or

Overall Status:


Study Phase:

Phase 3



Minimum Age:

18 Years

Maximum Age:


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Ethicon, Inc.

Oversight Authority:

United States: Food and Drug Administration

Reasons Why Stopped:

Study Type:


Study Design:

Allocation: Randomized, Endpoint Classification:

Number of Arms:


Number of Groups:


Total Enrollment:


Enrollment Type:

Study Dates

Start Date:June 2005
Completion Date:March 2006
Verification Date:July 2006
Last Changed Date:July 11, 2006
First Received Date:September 7, 2005

Study Outcomes

Outcome Type:Primary Outcome
Measure:Attainment of hemostasis at following randomization.
Safety Issues:False
Outcome Type:Secondary Outcome
Measure:Attainment of hemostasis following randomization.
Safety Issues:False
Outcome Type:Secondary Outcome
Measure:Incidence of treatment failures
Safety Issues:False
Outcome Type:Secondary Outcome
Measure:Incidence of potential bleeding-related complications
Safety Issues:False
Outcome Type:Secondary Outcome
Measure:Adverse events
Safety Issues:False

Study Interventions

Intervention Type:Drug
Name:Fibrin sealant (FS2)

Study Arms

There are no available Study Arms

Study Agencies

Agency Class:Industry
Agency Type:Lead Sponsor
Agency Name:Ethicon, Inc.
Agency Class:Industry
Agency Type:Collaborator
Agency Name:OMRIX Biopharmaceuticals

Sample and Retention Information

There are no available Sample and Retention Information

Study References

There are no available Study References

Data Source:

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

This study is not currently recruiting Study Participants. The form below is not enabled.